K. Lutfy et al., Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat, NEUROREPORT, 10(1), 1999, pp. 103-106
RECENT studies that intracerebroventricular (i.c.v.) administration of orph
anin FQ (OFQ) blocks opioid-induced antinociception in a variety of animal
models of pain. In the present study, we sought to investigate the inhibito
ry effect of OFQ on morphine-induced antinociception using the hot plate te
st in rats and to examine whether tolerance develops to the anti-opioid eff
ect of the peptide. Microinjection of OFQ (50 nmol, i.c.v.) significantly a
ttenuated the antinociceptive effect of morphine without affecting baseline
hot plate latencies, suggesting that modification of morphine-induced anti
nociception can be achieved via activation of the ORL-1 receptor by OFQ wit
h no apparent mu opioid receptor blockade or interference with basal nocice
ptive responses. Chronic treatment with OFQ (50 nmol/day for 5 days) produc
ed a complete loss of the inhibitory effect of the peptide indicating that
tolerance developed to the anti-opioid effect of OFQ. Taken together, these
results indicate that neuronal plasticity may occur following chronic use
of OFQ as is evident for the other opioid agonists. (C) 1999 Lippincott Wil
liams & Wilkins.